Daniel Vaena Selected Research

Daniel Vaena Research Topics

8	Neoplasms (Cancer) 06/2023 - 08/2014
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2023
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 08/2014
1	Colorectal Neoplasms (Colorectal Cancer) 06/2023
1	Proteinuria 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Disease Progression 01/2017
1	Clinical Deterioration 01/2017
1	Melanoma (Melanoma, Malignant) 01/2015

4	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2017
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2017
1	EpitopesIBA 12/2021
1	Gemcitabine FDA Link 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Sunitinib (Sutent)FDA Link 01/2020
1	pazopanib FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	CD40 Ligand (CD40L)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 10/2018
1	Everolimus FDA Link 10/2018
1	cabozantinibIBA 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2018
1	Immunoglobulin G (IgG)IBA 01/2017
1	NivolumabIBA 01/2017
1	PlatinumIBA 01/2017
1	Prostate-Specific Antigen (Semenogelase)IBA 08/2014
1	CytokinesIBA 08/2014
1	VaccinesIBA 08/2014